Matthew Ngo, MD
Clinical Cardiac Electrophysiology · Richmond, VANPI 1912060609
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (52.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Medtronic at 33.5% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in VA, where the typical reported total is $19,771.
Across 212 payments — averaging $42.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$3K
- Sanofi-aventis U.S. LLC$338
- Amgen$304
- Boston Scientific$269
- Novartis$250
- plus $2K from 28 others
Across 56 payments — averaging $311.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$14K
- Abbott$4K
What the payments were for
- Travel & lodging$4,77253%
- Food & beverage$4,16946%
- Education$1111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 28 | $3,034 |
| Abbott | 12 | $2,898 |
| Sanofi-aventis U.S. LLC | 20 | $338 |
| Amgen | 19 | $304 |
| Boston Scientific | 10 | $269 |
| Novartis | 15 | $250 |
| Pfizer | 15 | $248 |
| Johnson & Johnson | 13 | $200 |
| Cardiva Medical, Inc. | 6 | $154 |
| E.r. Squibb & Sons, L.L.C. | 12 | $148 |
| Boehringer Ingelheim | 7 | $127 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $115 |
| Cook Medical LLC | 1 | $105 |
| Actelion Pharmaceuticals US, Inc. | 2 | $102 |
| Philips North America LLC | 6 | $102 |
| Amarin Pharma, Inc. | 5 | $91 |
| Astellas Pharma US Inc | 4 | $75 |
| Lundbeck LLC | 5 | $71 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Kestra Medical Technology Services, Inc. | 2 | $39 |
| AstraZeneca | 3 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Novo Nordisk | 2 | $29 |
| Elutia, Inc. | 2 | $29 |
| Solventum Corporation | 1 | $29 |
| Portola Pharmaceuticals, LLC | 1 | $25 |
| Esperion Therapeutics, Inc. | 2 | $24 |
| Eagle Pharmaceuticals, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Atricure, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Biotronik Inc. | 1 | $19 |
| Heartflow, Inc. | 1 | $18 |
| Vital Connect, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,052 in reported general payments places this provider in the 30th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 500 | $574,849 |
| XareltoRivaroxaban | 96 | $114,630 |
| EntrestoSacubitril/Valsartan | 97 | $106,341 |
| MultaqDronedarone Hcl | 29 | $40,775 |
| JardianceEmpagliflozin | 28 | $36,290 |
| Mexiletine Hcl | 65 | $6,235 |
| Flecainide Acetate | 155 | $5,233 |
| Metoprolol Succinate | 410 | $4,942 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 112 | $3,060 |
| Amiodarone Hcl | 190 | $3,042 |
| Diltiazem Hcl | 27 | $1,784 |
| Midodrine Hcl | 32 | $1,590 |
| Bumetanide | 64 | $1,501 |
| Carvedilol | 160 | $1,463 |
| ClopidogrelClopidogrel Bisulfate | 95 | $1,222 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $248 | $574,849500 claims |
| Johnson & JohnsonXarelto | $200 | $114,63096 claims |
| NovartisEntresto | $250 | $106,34197 claims |
| Sanofi-aventis U.S. LLCMultaq | $338 | $40,77529 claims |
| Boehringer IngelheimJardiance | $127 | $36,29028 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Richmond
- Kenneth EllenbogenRichmond$360K
- Ajay PillaiRichmond$129K
- Charles JoynerRichmond$85K
- Binaya BasyalRichmond$79K
- Jayanthi KoneruRichmond$62K
- Kyaw Min KhantRichmond$51K
- Jacob BlackwellRichmond$49K
- Pranav MankadRichmond$30K
- Vybhav JettyRichmond$20K
- Harsimran SainiRichmond$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.